Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal year 2015 of $102.5 billion, an increase of 13 percent year-over-year. Profit increased 4 percent to $1.2 billion.

For the fiscal year, sales for the pharmaceutical segment increased 14 percent to $80.1 billion and profit increased 20 percent to $1.7 billion.

Sales for the medical segment were up 4 percent to $11.4 billion and profit decreased 3 percent to $444 million.

For the fiscal fourth quarter, total sales were $$27.5 billion, an increase of 20 percent year-over-year. Profit increased 26 percent to $295 million.

During the year, the company also operationalized Red Oak Sourcing, its generic sourcing venture with CVS Health, agreed to acquire The Harvard Drug Group and acquired Metro Medical.